Matinas BioPharma (NYSE:MTNB) said on Friday that it hasreceivedan NYSE American notice indicating that the company has fallen below certain NYSE American continued listing standards because it failed to hold its annual meeting of stockholders for the fiscal year ending on December 31, 2024. The ...
Matinas BioPharma Holdings, Inc. today reported financial results for the third quarter ended September 30, 2021, along with a corporate update.
雪球为您提供Matinas Biopharma(MTNB)股票实时行情,资金流向,新闻资讯,研究报告,社区互动,交易信息,个股点评,公告,财务指标分析等与Matinas Biopharma(MTNB)股票相关的信息与服务.
Matinas BioPharma 收到纽交所不合规通知 新泽西州贝德明斯特,2025年1月10日(GLOBE NEWSWIRE)-- Matinas BioPharma Holdings, Inc.(纽交所美国:MTNB)宣布,2025年1月6日,其收到了一份纽交所美国有限公司通知,指示 GlobeNewswire01/11 06:15 Matinas BioPharma股票因下跌暂停交易;目前上涨3.15% Matinas BioPharma股...
Matinas BioPharma董事会主席宣布离职 根据最新的SEC文件显示,目前股价为$0.55、市值279万美元的Matinas BioPharma Holdings, Inc.(NYSE American: MTNB)董事会主席Eric Ende已于今日辞职。这次离职发生在2025年3月13日,原因是Ende需要专注于其他职业承诺,而非因与公司方向或运营有任何实质性分歧。
这也意味着BioNTech和Matinas结束口服mRNA疫苗合作。 Jerome D. Jabbour说:“这虽然令人失望,但也让我们认识到我们任重而道远,这是一种新的、独特的信使核糖核酸制剂的首次体内研究,迄今为止,还没有任何递送技术成功实现mRNA的递送。” 2022...
BioNTech SE and Matinas BioPharma have entered into an exclusive research collaboration to evaluate the combination of mRNA formats and Matinas’ proprietary LNC platform technology. The parties will closely collaborate on formulation, optimization, and in v...
Analyst Ratings for Matinas Biopharma Hl (MTNB) provide recommendations made by outside industry experts.
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors See more News & More Feb 13, 2025 Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors Feb 7, 2025 Matinas BioPharma Appoints Evelyn ...